Brief: Silk Road Medical Reports Second Quarter Results
26/07/2022 23:19
July 26 (Reuters) - Silk Road Medical Inc SILK.O :
* SILK ROAD MEDICAL REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
* REVENUE FOR Q2 OF 2022 WAS $33.2 MILLION
* GROSS PROFIT FOR Q2 OF 2022 WAS $24.2 MILLION
* NET LOSS WAS $15.4 MILLION IN Q2 OF 2022
* PROJECTS REVENUE FOR FULL YEAR 2022 TO RANGE FROM $128
MILLION
TO $133 MILLION, WHICH REPRESENTS 26% TO 31% GROWTH OVER
COMPANY'S PRIOR YEAR REVENUE
Source text for Eikon: ID:nGNX5xf03n
Further company coverage: SILK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Silk Road Medical
See all newsBrief: Silk Road Medical Boston Scientific To Be Required To Pay Co Termination Fee Of $69.5 Million If Merger Agreement Terminated Under Certain Circumstances
Boston Scientific to buy Silk Road Medical in $1.16 billion deal (updated)
Brief: Boston Scientific Announces Agreement to Acquire Silk Road Medical
Brief: Silk Road Medical Announces Definitive Agreement To Be Acquired By Boston Scientific
Boston Scientific to buy Silk Road Medical for $1.16 billion